Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1640968 | 0.87 | — | — | |
| SCHEMBL3241102 | 0.77 | CBFB (0.34) | — | |
| SCHEMBL3243506 | 0.76 | — | — | |
| SCHEMBL1639456 | 0.74 | — | — | |
| SCHEMBL1640279 | 0.73 | CBFB (0.34) | — | |
| SCHEMBL17651806 | 0.72 | — | — | |
| SCHEMBL241718 | 0.71 | — | — | |
| SCHEMBL3270945 | 0.70 | — | — | |
| SCHEMBL23628544 | 0.69 | — | — | |
| SCHEMBL1438735 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2192899-B1 | TRANSITION METAL COMPLEXES OF CORROLES FOR PREVENTING CARDIOVASCULAR DISEASES OR DISORDERS | TECHNION RES & DEV FOUNDATION (IL) | 2014-10-01 | — | — | EP | disclosed |
| US-8791099-B2 | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2014-07-29 | — | — | US | disclosed |
| US-20140045809-A1 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2014-02-13 | — | — | US | disclosed |
| EP-2244701-B1 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | TECHNION RES & DEV FOUNDATION (IL) | 2012-05-09 | — | — | EP | disclosed |
| US-20110144078-A1 | TRANSITION METAL COMPLEXES OF CORROLES FOR PREVENTING CARDIOVASCULAR DISEASES OR DISORDERS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2011-06-16 | — | — | US | disclosed |
| US-20110098262-A1 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | TECHNION RESEARCH AND DEVELOPEMENT FOUNDATION, LTD. (IL) | 2011-04-28 | — | — | US | disclosed |
| EP-2244701-A2 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | Technion Research and Development Foundation, Ltd. (IL) | 2010-11-03 | — | — | EP | disclosed |
| EP-2192899-A1 | TRANSITION METAL COMPLEXES OF CORROLES FOR PREVENTING CARDIOVASCULAR DISEASES OR DISORDERS | Technion Research and Development Foundation, Ltd. (IL) | 2010-06-09 | — | — | EP | disclosed |
| WO-2009095923-A2 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD (IL) | 2009-08-06 | — | — | WO | disclosed |
| WO-2009027965-A1 | TRANSITION METAL COMPLEXES OF CORROLES FOR PREVENTING CARDIOVASCULAR DISEASES OR DISORDERS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098262-A1 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | IAPP, CASP3, SOD1 | HSD17B10 2689/4885 |
| US-20140045809-A1 | CORROLES FOR NEUROPROTECTION AND NEURORESCUE | IAPP, CASP3, SOD1 | HSD17B10 2689/4885 |
| US-20110144078-A1 | TRANSITION METAL COMPLEXES OF CORROLES FOR PREVENTING CARDIOVASCULAR DISEASES OR DISORDERS | FABP3, SLC39A14, SLC39A3 | HSD17B10 915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.